J8610 Methotrexate - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Methotrexate

Brand Name:

Trexall

Strength:

2.5 mg

HCPCS:

J8610

SEER*Rx Category:

Chemotherapy

Major Drug Class:

Antimetabolite

Minor Drug Class:

Folic Acid Analog

Oral (Y/N):

Yes

FDA Approval Year:

1953

FDA Discontinuation Year:

CMS Effective Date:

Jan. 1, 1995

CMS Discontinuation Date:

Status:

In Use